[go: up one dir, main page]

DE60129800D1 - Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze - Google Patents

Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze

Info

Publication number
DE60129800D1
DE60129800D1 DE60129800T DE60129800T DE60129800D1 DE 60129800 D1 DE60129800 D1 DE 60129800D1 DE 60129800 T DE60129800 T DE 60129800T DE 60129800 T DE60129800 T DE 60129800T DE 60129800 D1 DE60129800 D1 DE 60129800D1
Authority
DE
Germany
Prior art keywords
perindopril
synthesis
acceptable salts
pharmaceutical acceptable
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129800T
Other languages
English (en)
Other versions
DE60129800T2 (de
Inventor
Pascal Langlois
Hugues Turbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8848925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60129800(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of DE60129800D1 publication Critical patent/DE60129800D1/de
Application granted granted Critical
Publication of DE60129800T2 publication Critical patent/DE60129800T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60129800T 2000-04-06 2001-04-05 Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze Expired - Lifetime DE60129800T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0004379A FR2807431B1 (fr) 2000-04-06 2000-04-06 Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR0004379 2000-04-06
PCT/FR2001/001026 WO2001058868A1 (fr) 2000-04-06 2001-04-05 Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
DE60129800D1 true DE60129800D1 (de) 2007-09-20
DE60129800T2 DE60129800T2 (de) 2008-06-05

Family

ID=8848925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129800T Expired - Lifetime DE60129800T2 (de) 2000-04-06 2001-04-05 Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze

Country Status (34)

Country Link
US (1) US6835843B2 (de)
EP (1) EP1268424B1 (de)
JP (1) JP3939553B2 (de)
KR (1) KR100507616B1 (de)
CN (1) CN1296355C (de)
AP (1) AP1385A (de)
AT (1) ATE369338T1 (de)
AU (2) AU2001248470B2 (de)
BG (1) BG65984B1 (de)
BR (1) BRPI0109836B1 (de)
CA (1) CA2405486C (de)
CY (1) CY1108522T1 (de)
CZ (1) CZ302575B6 (de)
DE (1) DE60129800T2 (de)
DK (1) DK1268424T3 (de)
EA (1) EA005079B1 (de)
EE (1) EE05032B1 (de)
ES (1) ES2291307T3 (de)
FR (1) FR2807431B1 (de)
GE (1) GEP20063797B (de)
HR (1) HRP20020876B1 (de)
HU (1) HU227674B1 (de)
ME (1) ME00441B (de)
MX (1) MXPA02009706A (de)
NO (1) NO324174B1 (de)
NZ (1) NZ521454A (de)
OA (1) OA12242A (de)
PL (1) PL204471B1 (de)
PT (1) PT1268424E (de)
RS (1) RS50808B (de)
SK (1) SK286921B6 (de)
UA (1) UA75070C2 (de)
WO (1) WO2001058868A1 (de)
ZA (1) ZA200207419B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827860B1 (fr) 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
ATE365714T1 (de) * 2002-01-30 2007-07-15 Servier Lab Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese
JP2005256847A (ja) * 2002-02-28 2005-09-22 Nsk Ltd 車輪用軸受ユニット
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
DE60301774T2 (de) * 2003-02-28 2006-07-20 Les Laboratoires Servier Verfahren zur Synthese von (2S,3aS,7aS)-1-((S)-Alanyl)-octahydro-1H-indol-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
CA2517205C (en) 2003-02-28 2010-08-24 Lupin Limited Process for preparation of perindopril and salts thereof
ATE307139T1 (de) * 2003-02-28 2005-11-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salze
SI1338591T1 (sl) * 2003-02-28 2006-02-28 Servier Lab NOV POSTOPEK ZA SINTEZO (2S,3aS,7aS)-PERHIDROINDOL-2-KARBOKSILNE KISLINE IN NJENIH ESTROV TER UPORABA PRI SINTEZI PERINDOPRILA
DK1321471T3 (da) * 2003-03-12 2005-08-29 Servier Lab Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
ES2231760T3 (es) * 2003-03-12 2005-05-16 Les Laboratoires Servier Nuevo procedimiento de sintesis del acido(2s, 3as,7as)perhidroindol-2-carboxilico y de sus esteres, y su aplicacion a la sintesis de perindopril.
PT1319668E (pt) * 2003-03-12 2005-02-28 Servier Lab Novo processo de sintese de derivados do acido (2s,3as,7as)-1-[(s)-alanil]-octa-hidro-1h-indole-2-carboxilico e aplicacao a sintese de perindopril
WO2004099138A2 (en) * 2003-05-12 2004-11-18 Cipla Limited Process for the preparation of perindopril
ATE540924T1 (de) 2003-06-24 2012-01-15 Servier Lab Neue kristalline formen von perindopril erbumine
SI1367063T1 (sl) * 2003-07-31 2006-10-31 Servier Lab Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
DK1367062T3 (da) * 2003-07-31 2007-01-02 Servier Lab Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
AU2003300689B2 (en) * 2003-10-21 2009-01-29 Les Laboratoires Servier Novel method for preparation of crystalline perindopril erbumine
ES2300555T3 (es) * 2003-12-10 2008-06-16 Les Laboratoires Servier Procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
HRP20161602T1 (hr) * 2004-03-29 2016-12-30 Les Laboratoires Servier Postupak priprave čvrstog farmaceutskog pripravka
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
EP1987828A1 (de) 2005-01-06 2008-11-05 IPCA Laboratories Limited perindopril-salzen und ihre verwendung bei der behandlung von hypertonie
US7291745B2 (en) * 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2007085933A2 (en) * 2006-01-25 2007-08-02 Glenmark Pharmaceuticals Limited Process for the preparation of n-[1-(s)-ethoxycarbonyl-1-butyl]-(s)-alanine-dmt complex and its use in the preparation of perindopril
WO2008114270A1 (en) * 2007-03-22 2008-09-25 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
AU2013328352A1 (en) * 2012-10-10 2015-05-14 Piramal Enterprises Limited An improved process for preparation of Perindopril intermediate
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN107098949B (zh) * 2017-04-20 2021-03-16 上药东英（江苏）药业有限公司 一种制备培哚普利叔丁胺盐的绿色合成新工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Also Published As

Publication number Publication date
ES2291307T3 (es) 2008-03-01
CN1420867A (zh) 2003-05-28
AP1385A (en) 2005-04-08
HUP0101336A2 (hu) 2002-02-28
ATE369338T1 (de) 2007-08-15
EP1268424B1 (de) 2007-08-08
KR100507616B1 (ko) 2005-08-10
PL204471B1 (pl) 2010-01-29
GEP20063797B (en) 2006-04-25
US6835843B2 (en) 2004-12-28
NO20024808D0 (no) 2002-10-04
SK14182002A3 (sk) 2003-02-04
MXPA02009706A (es) 2004-09-06
ME00441B (me) 2011-10-10
EA005079B1 (ru) 2004-10-28
BG65984B1 (bg) 2010-08-31
CZ302575B6 (cs) 2011-07-20
EE200200575A (et) 2004-04-15
CA2405486A1 (fr) 2001-08-16
NZ521454A (en) 2004-03-26
RS50808B (sr) 2010-08-31
JP3939553B2 (ja) 2007-07-04
HK1053309A1 (en) 2003-10-17
CZ20023291A3 (cs) 2003-02-12
DK1268424T3 (da) 2007-12-17
FR2807431A1 (fr) 2001-10-12
SK286921B6 (sk) 2009-07-06
US20030069431A1 (en) 2003-04-10
HRP20020876B1 (en) 2010-10-31
JP2003531825A (ja) 2003-10-28
NO324174B1 (no) 2007-09-03
HU0101336D0 (en) 2001-06-28
DE60129800T2 (de) 2008-06-05
PL346555A1 (en) 2001-09-10
NO20024808L (no) 2002-10-04
EP1268424A1 (de) 2003-01-02
AU2001248470B2 (en) 2005-01-20
PT1268424E (pt) 2007-10-16
AU4847001A (en) 2001-08-20
EA200201057A1 (ru) 2003-06-26
HRP20020876A2 (en) 2004-02-29
FR2807431B1 (fr) 2002-07-19
BG107249A (bg) 2003-07-31
KR20030013381A (ko) 2003-02-14
BRPI0109836B1 (pt) 2015-08-04
CN1296355C (zh) 2007-01-24
CY1108522T1 (el) 2014-04-09
OA12242A (en) 2003-12-08
YU73802A (sh) 2006-01-16
UA75070C2 (uk) 2006-03-15
HU227674B1 (hu) 2011-11-28
CA2405486C (fr) 2008-07-29
HUP0101336A3 (en) 2003-03-28
ZA200207419B (en) 2003-09-16
WO2001058868A1 (fr) 2001-08-16
AP2002002630A0 (en) 2002-09-30
EE05032B1 (et) 2008-06-16
BR0109836A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
DE60129800D1 (de) Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
ATE414519T1 (de) Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit
DZ3268A1 (fr) Synthese asymetrique de pregabaline
MA27392A1 (fr) Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
ATE283273T1 (de) Hemisynthetisches verfahren und dessen zwischenprudukte
ATE249435T1 (de) Neue kristalline form gamma des tert-butylamin salzes von perindopril, verfahren zu deren herstellung und dieses enthaltende arzneimittel
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
DE60303101D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60311942D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60313391D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch geeigneten Salze
PT1060175E (pt) Inibidores de triptase
DE60300581D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60301820D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60308102D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen i2003/26ö
DE60001725D1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
MA24644A1 (fr) Methode pour la synthese des derives de la quinoline
DE69522642D1 (de) Hymenialdisin und seine derivate, verfahren zur herstellung von zwischenprodukten zu ihrer synthese und besagte zwischenprodukte
DE60128554D1 (de) Verfahren zur herstellung von estern des n-ä(s)-1-carboxybutylü-(s)-alanins und ihre verwendung in der synthese von perindopril
DE60319196D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60302287D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE69937692D1 (de) Arzneimittel zur behandlung der hemicrania
DE60307721D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition